Обнаружение вируса папилломы человека методом самозабора (Self-sampling): новая модель скрининга рака шейки матки
Ключевые слова:
скрининг рака шейки матки, вирус папилломы человека, метод самозабора Self samplingАннотация
В статье представлены преимущества скрининга рака шейки матки на основе выявления онкогенных штаммов вируса папилломы человека перед традиционным цитологическим скринингом методом РАР-теста. Метод самозабора Self sampling с помощью инструмента Qvintip компании Aprovix (Швеция) позволяет увеличить процент женщин, участвующих в национальных программах популяционного скрининга, что приведет к улучшению показателей заболеваемости и смертности женского населения от рака шейки матки.
Библиографические ссылки
«Cervical screening: programme overview». GOV.UK. Public Health England.
«Leopold Koss». New York Times. Legacy.com. September 15, 2012. Retrieved 14 October 2012.
Andrae B, Kemetli L, Sparén P, Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden. J Natl Cancer Inst. 2008;100:605–606.
Arbyn, M. et al. Worldwide burden of cervical cancer in 2008. Ann. Oncol. 22, 2675–2686 (2011).
Baseman, J. G. & Koutsky, L. A. The epidemiology of human papillomavirus infections. J. Clin. Virol. 32 (Suppl. 1), S16–S24 (2005).
Chow, L. T., Broker, T. R., & Steinberg, B. M. The natural history of human papillomavirus infections of the mucosal epithelia. APMIS 118, 422–449 (2010).
Dhiraj B. Nikumbh, Roopali D. Limitations of cytological cervical cancer screening (Papanicolaou test) regarding technical and cultural aspect in rural IndiaAsian J Cancer. 2016 Apr-Jun; 5(2): 79.
Doorbar, J. Molecular biology of human papillomavirus infection and cervical cancer. Clin. Sci. 110, 525–541 (2006).
Doorbar, J. Molecular biology of human papillomavirus infection and cervical cancer. Clin. Sci. 110, 525–541 (2006).
Durst, M., Gissmann, L., Ikenberg, H. & zur Hausen, H. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc. Natl Acad. Sci. USA 80, 3812–3815 (1983).
I Wikström, M Lindell, K Sanner, and E Wilander. Self-sampling and HPV testing or ordinary Pap-smear in women not regularly attending screening: a randomised study Br J Cancer. 2011 Jul 26; 105(3): 337–339.
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. — IARC, 2006.
IARC. A review of human carcinogens — PartB: biological agents. 100B, (2011).
Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61:69.
Jentschke M, Chen K, Arbyn M. Direct comparison of two vaginal self-sampling devices for the detection of human papillomavirus infections. J Clin Virol. 2016 Sep;82:46-50.
M.J. O’Dowd, E.E. Philipp, The History of Obstetrics & Gynaecology, London, Parthenon Publishing Group, 1994, p. 547.
McCredie, M. R. et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol. 9, 425–434 (2008).
McLaughlin-Drubin, M. E. & Munger, K. Viruses associated with human cancer. Biochim. Biophys. Acta 1782, 127–150 (2008).
Meijer CJ, Berkhof J, Castle PE, Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. Int J Cancer. 2009;124:516–520.
Moore, P. S. & Chang, Y. Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat. Rev. Cancer 10, 878–889 (2010).
Nathan A. Krump & Jianxin You Molecular mechanisms of viral oncogenesis in humans Nature Reviews Microbiology volume 16, pages684–698 (2018)
Nayar R., Wilbur D.C. The Pap Test and Bethesda 2014 Acta Cytologica 2015; 59:121-132
Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective.
Peto, J., Gilham, C., Fletcher, O. & Matthews, F. E. The cervical cancer epidemic that screening has prevented in the UK. Lancet 364, 249–256 (2004).
Petry K.U.a · Wörmann B.b · Schneider A. Benefits and Risks of Cervical Cancer Screening Oncol Res Treat 2014; 37(suppl 3):48-57
Petry KU J HPV and cervical cancer. Clin Lab Invest Suppl. 2014; 244:59-62;
Ronco G, Dillner J, Elfström KM. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet. 2014 Feb 8;383(9916):524-32.
Ronco G, Giorgi-Rossi P, Carozzi F, New Technologies for Cervical Cancer screening (NTCC) Lancet Oncol. 2010;11:249–257.
Sanner K, Wikström I, Strand A. Self-sampling of the vaginal fluid at home combined with high-risk HPV testing. Br J Cancer. 2009;101:871–874
Saraiya M, Unger ER, Thompson TD, US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. l Cancer Inst. 2015 Apr 29;107(6):djv086.
Snijders, P. J., Steenbergen, R. D., Heideman, D. A. & Meijer, C. J. HPV-mediated cervical carcinogenesis: concepts and clinical implications. J. Pathol. 208, 152–164 (2006).
Jablonska Stefania BMJ 2017; 357 Cite this as: BMJ 2017; 357:j2891
Vink, M. A. et al. Clinical progression of high-grade cervical intraepithelial neoplasia: estimating the time to preclinical cervical cancer from doubly censored national registry data. Am. J. Epidemiol. 178, 1161–1169 (2013)
Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189:12.
Wikström I, Stenvall H, Wilander E. Attitudes to self-sampling of vaginal smear for human papilloma virus analysis among women not attending organized cytological screening. Acta Obstet Gynecol Scand. 2007a;86:720–725.
Wilson, James Maxwell Glover, Jungner, Gunnar & World Health Organization. (1968). Principles and practice of screening for disease / J. M. G. Wilson, G. Jungner. World Health Organization.
Winkelstein, Warren «Vignettes of the History of Epidemiology: Three Firsts by Janet Elizabeth Lane-Claypon». American Journal of Epidemiology. 160 (2): 97–101
Zucchetto A, Ronco G, Giorgi Rossi P, et al. Screening patterns within organized programs and survival of Italian women with invasive cervical cancer. Prev Med 2013; 57: 220–26.
Zur Hausen, H. & de Villiers, E. M. Cancer “causation” by infections — individual contributions and synergistic networks. Semin. Oncol. 41, 860–875 (2014).
zur Hausen, H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J. Natl Cancer Inst. 92, 690–698 (2000).
Дополнительные файлы
Опубликован
Как цитировать
Выпуск
Раздел
Лицензия
Публикуемые в этом журнале статьи размещены под лицензией CC BY-NC-ND 4.0 (Creative Commons Attribution — Non Commercial — No Derivatives 4.0 International), которая предусматривает только их некоммерческое использование. В соответствии с этой лицензией пользователи имеют право копировать и распространять материалы, охраняемые авторским правом, но им не разрешается изменять или использовать их в коммерческих целях. Полная информация о лицензировании доступна по адресу https://creativecommons.org/licenses/by-nc-nd/4.0/.
